DISCUSSION: The prime consideration in managing our case was to avoid
bronchospasm and maintaining hemodynamic stability during surgery (8, 9) The case study shows the safety and efficacy of combined cervical and interscalene block in shoulder surgery in patients with CAD and COPD who have higher morbidity and mortality under General anaesthesia (10-13)
This medication can be used to help treat an asthma attack, prevent future episodes of asthma, or prevent exercise induced
bronchospasm. In the latter situation it may be used 30 minutes to several hours prior to exercise.
The FDA approved Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, a hydrofluoroalkane metered-dose inhaler (MDI) for treatment or prevention of
bronchospasm in adults, adolescents, and children at least 4 years old with reversible obstructive airway disease.
The goal of therapy is to get as much effect (relief of
bronchospasm) as possible without side effect (fast heart rate and a child bouncing off the walls).
Pharmaceutical company Teva Pharmaceutical Industries (NYSE:TEVA) said on Thursday that its supplemental new drug application (sNDA) for ProAir RespiClick Inhalation Powder has been accepted by the US Food and Drug Administration (FDA) for review for the treatment or prevention of
bronchospasm in pediatric patients.
Lierl uses Foradil as a pretreatment to prevent exercise-induced
bronchospasm in older children, such as those who run track.
* Special Considerations: Atrovent HFA is not indicated for initial treatment of acute
bronchospasm where a rapid response is required.
She reported on 94 Italian children aged 1-10 years who presented to a pediatric emergency department with an episode of nonallergic
bronchospasm associated with fever and signs or symptoms of upper respiratory tract infection.
Xopenex (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of
bronchospasm in adults, adolescents and children six years of age and older with reversible obstructive airway disease, said Akorn.
This is of interest because oral beta-blockers, including propranolol, have been associated with rare but serious adverse events, such as
bronchospasm, hypotension, and hypoglycemia.
In addition, obese patients with asthma or
bronchospasm make these difficulties even more challenging.